Fyodor today announced that Chairman and CEO Dr Eddy Agbo will speak on ‘Frugal Innovations in Medicine’ at the 2018 MedTech Summit, Nuremberg, Germany, at 9.20 AM CET / 8.20 AM WAT / 3.20 AM US ET).
The summit, to be held in partnership with MT-Connect under the auspices of the Bavarian Ministry of Economic Affairs is the premier global forum for medical device manufacturers, clinicians, scientists and suppliers in the medical technology space. The conference details are available at the MedTech Summit website.
About Fyodor
Fyodor is a leading fever diagnostics biotech company delivering a portfolio of non-invasive products that address global health diseases in emerging markets. We create consumer-facing medical diagnostic products that empower patient-centric healthcare management to expand and democratize access to appropriate individualized care in home settings. Fyodor has commercialized the Urine Malaria Test (UMT) – the first and only non-blood dipstick test that tells within 25 minutes if a fever is malaria, using a few drops of urine, and works just like a pregnancy test. With the UMT, we are democratizing malaria testing, making it possible for anyone, anywhere, to promptly test, to save lives at scale.
Contact
Fyodor Biotechnologies
Ph: 1-443-300-6236